ERBB2 and breast carcinoma: We developed a realistic model of PIK3CA mutation in the HER2+, luminal subtype breast cancer cell line SK-BR-3 by using adeno-associated virus (AAV) vectors to deliver sequences for homology-mediated recombination at the PIK3CA locus as previously described [23].